X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (90) 90
humans (71) 71
index medicus (68) 68
female (45) 45
aged (44) 44
male (39) 39
middle aged (39) 39
chemotherapy (34) 34
adult (30) 30
cancer (23) 23
aged, 80 and over (21) 21
prognosis (21) 21
treatment outcome (20) 20
care and treatment (17) 17
colorectal cancer (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
retrospective studies (15) 15
breast cancer (14) 14
survival (14) 14
disease-free survival (13) 13
bevacizumab (12) 12
colorectal neoplasms - pathology (12) 12
carcinoma, non-small-cell lung - drug therapy (11) 11
colorectal neoplasms - drug therapy (11) 11
tumors (11) 11
antineoplastic agents - therapeutic use (10) 10
lung neoplasms - drug therapy (10) 10
metastasis (10) 10
non-small cell lung cancer (10) 10
pharmacology & pharmacy (10) 10
survival analysis (10) 10
analysis (9) 9
lung cancer (9) 9
time factors (9) 9
trial (9) 9
1st-line treatment (8) 8
cancer therapies (8) 8
disease progression (8) 8
docetaxel (8) 8
double-blind (8) 8
hematology (8) 8
medical prognosis (8) 8
mutation (8) 8
respiratory system (8) 8
therapy (8) 8
biomarkers (7) 7
breast neoplasms - drug therapy (7) 7
breast neoplasms - pathology (7) 7
breast-cancer (7) 7
colorectal neoplasms - mortality (7) 7
gastric cancer (7) 7
hematology, oncology and palliative medicine (7) 7
management (7) 7
medicine & public health (7) 7
open-label (7) 7
research (7) 7
risk factors (7) 7
angiogenesis (6) 6
colorectal neoplasms - genetics (6) 6
combination (6) 6
health care sciences & services (6) 6
lung neoplasms - pathology (6) 6
medicine (6) 6
mortality (6) 6
neoplasm staging (6) 6
oncology, experimental (6) 6
palliative care (6) 6
surgery (6) 6
survival rate (6) 6
targeted therapy (6) 6
age factors (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
biopsy (5) 5
brain metastases (5) 5
cancer research (5) 5
capecitabine (5) 5
carcinoma (5) 5
case report (5) 5
clinical-trials (5) 5
cohort studies (5) 5
decision making (5) 5
deoxycytidine - analogs & derivatives (5) 5
diagnosis (5) 5
immunotherapy (5) 5
internal medicine (5) 5
patients (5) 5
phase-iii trial (5) 5
quality of life (5) 5
ramucirumab (5) 5
usage (5) 5
angiogenesis inhibitors - therapeutic use (4) 4
animals (4) 4
antineoplastic agents (4) 4
antineoplastic agents - pharmacology (4) 4
brain cancer (4) 4
brain neoplasms - secondary (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
cetuximab (4) 4
classification (4) 4
cyclooxygenase 2 - metabolism (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2014, Volume 32, Issue 21, pp. 2240 - 2247
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 12/2018, Volume 140, Issue 3, pp. 559 - 568
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 574 - 581
The combination of gemcitabine and oxaliplatin with panitumumab versus gemcitabine and oxaliplatin alone has been evaluated in a phase 2, randomized trial as a... 
KRAS | panitumumab | biliary cancer | chemotherapy | cholangiocarcinoma | gemcitabine and oxaliplatin (GEMOX) | GROWTH-FACTOR-RECEPTOR | GALLBLADDER CANCER | OPEN-LABEL | II TRIAL | CAPECITABINE | ADVANCED CHOLANGIOCARCINOMA | CETUXIMAB | THERAPY | ONCOLOGY | Adenocarcinoma - pathology | Prognosis | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Adult | Female | Adenocarcinoma - genetics | Bile Duct Neoplasms - genetics | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Bile Ducts, Intrahepatic - pathology | Deoxycytidine - administration & dosage | Gallbladder Neoplasms - genetics | Treatment Outcome | Adenocarcinoma - drug therapy | Disease-Free Survival | Cholangiocarcinoma - pathology | Gallbladder Neoplasms - drug therapy | Cholangiocarcinoma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cholangiocarcinoma - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Bile Ducts, Extrahepatic - pathology | Gallbladder Neoplasms - pathology | Bile Duct Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Clinical trials | Usage | Dosage and administration | Gemcitabine | Index Medicus | Abridged Index Medicus
Journal Article
Occupational and Environmental Medicine, ISSN 1351-0711, 09/2016, Volume 73, Issue Suppl 1, pp. A61 - A61
PurposeIn 2002 subjects already enrolled in a surveillance program for asbestos-exposed workers were recruited in a Low Dose CT scan screening (LDCT) (ATOM002... 
Journal Article